Stability Indicating Method For The Simultaneous Estimation Of Cefuroxime Axetil And Line-zolid In Pharmaceutical Dosage Forms
Keywords:
Cefuroxime Axetil, Linezolid, Stability indicating RP-HPLC MethodAbstract
A simple, rapid, accurate and economical stability indicating RP-HPLC method has been developed for simultaneous estimation of Cefuroxime Axetil & Linezolid pharmaceutical dosage under different stress conditions For the analysis, HPLC LC- 20 AT SPD 20A UV detector at 240 nm and C18 (250mm x 4.6 mm) column was used. The selected mobile phase was Potassium phosphate (pH 5.0) and Acetonitrile (60:40v/v) in isocratic mode at a flow rate of 1 mL/min. Retention time of Linezolid and Cefuroxime Axetil were found to be 3.713 min and 6.107 min respectively. The methods are found to be specific as there was no interference of any co-eluting impurities after stress degradation study. The degraded products are well resolved, indicating the method can also be useful for determination of degraded products.
Downloads
References
“Drug profile for Cefuroxime”, September 2015, http://www.drugbank.ca/drugs/DB01112
“Drug profile for Cefuroxime”, September 2015, http://en.wikipedia.org/wiki/Cefuroxime
“Drug profile for Linezolid”, September 2015, http://www.drugbank.ca/drugs/DB00601
Expert Committee, Monograph Development-Antibiotics USP31–NF26 (MDANT05), pp 1698
European Pharmacopoeia, 6th Edition; Medicinal and Pharmaceutical Substances, 2009, pp 1462-1464.
British Pharmacopoeia 2009, Volume I &II,Monographs; Medicinal and Pharmaceutical Substances, Cefuroxime Axetil, pp 1173-1175.
Indian Pharmacopoeia 2010, Government of India, Ministry of Health and Family Welfare, Ghaziabad, Volume No-2,pp 263-264, 1590-1591.
Shinde MV, Pishawikar SA, and More HN, “Spectrophotometeric Determination of Cefuroxime Axetil from bulk and in its tablet dosage form.” Ind. J. Pharm. Sci. 2008, 70(2), 249–251.
Shelke S, Dongre S, Rathi A, Dhamecha D, Maria S, and Hassan M, “Development and Validation of UV Spectrophotometric Method of Cefuroxime Axetil in Bulk and Pharmaceutical Formulation.” Asian. J. Research Chem., 2009, 2(2), 222-224.
Jain P, Patel M and Surana S, “Development and validation of UV Spectrophotometric method for determination of Cefuroxime Axetil in bulk and in Formulation.” Inter. J. Drug Devel. & Rese.2011, 3(4), 318-322.
Sengar MR, Gandhi SV, Rajmane V, Patil UP and Gandhi BB, “Simultaneous Determination of Cefu-roxime Axetil and Potassium Clavulanate in Tablet Dosage Form by Spectrophotometry.” Res. J. Pharm. and Tech, 2010,3(1), 260-262.
Ranjane PN, Gandhi SV, Kadukar SS and Ranher SS, “Simultaneous determination of Cefuroxime axetil and Ornidazole in tablet dosage form using reversed-phase high performance liquid chromatography.” Chinese. J. Chroma. 2008, 26(6), 763–765.
Sengar MR, Gandhi SV, Rajmane V, Patil UP and Gandhi BB, “Reverse phase High performance liquid chromatography for simultaneous determination of Cefuroxime axetil and Potassium clavulanate in tablet dosage form.” Inter. J. Chem. Tech. Res. 2009, 1(4), 1105-1108.
Ingale PL, Dalvi SD, Jadav DD, Gudi SV, Patil LD, And Kadam YA, “Simultaneous determination of Cefuroxime axetil and Potassium Clavulanate in pharmaceutical dosage form by RP- HPLC.” Inter. J. Pharm and Pharm. Sci. 2013, 5(4), 179-181.
Maste MM, Mandavkar YD and Bhat AR, “High Performance Thin Layer Chromatographic Estimation of Cefuroxime Axitel in Bulk and Pharmaceutical Formulation.” International J. Pharm Research.2012, 4(1), 26-28.
Sengar MR, Gandhi SV, Rajmane V and Patil UP, “HPTLC Determination of Cefuroxime Axetil and Ornidazole in Combined Tablet Dosage Form.”J. Chroma. Sci. 2010, 48(1), 26-28.
The United State Pending Monograph, Correspondence Number C97768, 2013.
Naik AD and Pai SP, “Spectrophotometric Method for Estimation of Linezolid in Tablet Formulation.” Asi. J. Biomed. andPharma. Sci. 2013, 3(21), 4-6.
Saikiran BH, Johny SK, Madhuri PL, “UV Spectroscopic Method for Estimation Of Linezolid In Tablets.” Int. j Pharma. Chem. and Bio Sci. 2013, 3(3), 729-731.
Gadhiya DT and Bagada HL, “Simultaneous Equation Method for the estimation of cefiximetrihydarte and linezolid in Their Combined Tablet Dosage Form By UV-visibleSpectrophotometry.” Int. Bul. Drug. res. 2013,3(5), 29-38.
Sangshetty JN, Rashid BS, Bhojane S and Zaheer Z, “Simultaneous Estimation of Cefixime and Linezolid in bulk and tablet dosage form.” Am. J. Pharma Tech. Res. 2013, 3(5), 350-358.
Clos A and Kus K, “Determination Of Linezolid In Human Serum By Reversed-Phase High-Performance Liquid ChromatographyWith Ultraviolet And Diode Array Detection.” Actapoloniea. Pharma. 2013, 70(4), 631-641.
Prasanti KJ and Sundar BS, “A Validated RP-HPLC Method For The Determination Of LinezolidIn Pharmaceutical Dosage Forms.” Int. J. Pharma. and Bio Sic. 2012, 3(3), 44-51.
Patel SA and Patel JV, “RP-HPLC Method For Simultaneous Estimation Of CefiximeTrihydrate And Linezolid In Tablet Dosage Form.” Int. J. Phram. chem. and Bio. Sci. 2013, 3(2), 372-379.
Mohpatra S, Annapurna MM, Kumar RV and Anwar M, “Validated Stability Indicating Rphplc Method For The Estimation Of Linezolid In A PharmaceuticalDosage Form.” J. liq. Chr. and Tech. 2011, 34(18), 2185-2195.
Patel NS, Tandel FB, Patel YD and Thakkar KB, “Development and Validation of Stability indicating HPLC Method for Simultaneous Estimation of Cefixime and Linezolid.” Ind. J. Pharm. Sci. 2014, 76(6), 535-540.
Patel SA, Patel PU, Patel NJ and Patel MM, “High performance thin layer chromatographic method for estimation of linezolid in tablets.” Ind. J. Pharm. Sci., 2007, 69(4), 571-574.
Philips OA, Abdel-Hamid ME and Al-Hassawi LA, “Determination of linezolid in human plasma by LC-MS MS.” Analyst. 2001, 126(5), 609-614.
Chen L, Borba BD and Rohrer J, “Determination of Morpholine in Linezolidby Ion Chromatography.” Thermo. Sci. 2013.
Prajapati BN and Mashru RC, “Quantification Of Linezolid And Cefuroxime Axetil By Chemometrics Assisted And RP-HPLC Methods Development And Validation.” Int. J. pharm. Sci. and res. 2016, 7(7), 3028-3038.
Kshirsagar RS, Menjogea A and SenH.Rapidly disintegrating sustained release cefuroxime axetil composition. European Patents EP1330250, 2003.
Raman JV, Rathod D, Vohra I, Chavan M and PonnaiahR.Process for the preparation of Linezolid. European Patents EP2516408 A1, 2012.
Rao DM, Reddy PK.Process for the preparation of linezolid and related compounds. The United State US7741480 B2, 2010.
Yan Z, Deng B, Huang Y, Zeng H and Li J.Cefuroximeaxetil granule and preparation method of same.WO2013097305, 2003.
Aggrarwal KV, Goel S and Mishra U.An optimized bilayered tablet dosage form with high rate of bioavailability of two active antibiotics cefuroxime and clavulanic acid.WO2013001541, 2013.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
